The World Health Organisation (WHO) standard prescription for bacterial vaginosis (BV) is delivered to women across the globe on a daily basis. A group of researchers decided to test its effectiveness.
Out of 482 women aged 14-51 that visited a specific sexual health clinic over the course of a year, 74 were found to have BV (15 per cent).
Out of those 74, 11 still had BV after being twice treated with antibiotics. About half the women received a follow-up examination, and out of those, 39 per cent still had BV after treatment, leaving a big question mark over the other half of the women who never came back.
The study – Effectiveness of current therapy of bacterial vaginosis1
Treatment 1
The first treatment was 2g of oral Metronidazole in a single dose. So, pop the pill and off you go.
Treatment 2
Treatment 2 consisted of 500mg of Metronidazole twice daily by mouth for a week, or alternatively, Clindamycin twice daily at a dose of 200mg for a week.
The conclusion
The researchers concluded that standard treatments for BV are not always effective, with no significant difference noticed in the different age groups.
References
- 1.Andreeva PΜ, Omar HΑ. Effectiveness of current therapy of bacterial vaginosis. International Journal of Adolescent Medicine and Health. Published online April 2002. doi:10.1515/ijamh.2002.14.2.145
Get a fresh perspective with a qualified, experienced vulvovaginal specialist naturopath.
This product has multiple variants. The options may be chosen on the product page
The most comprehensive vaginal microbiome test you can take at home, brought to you by world-leading vaginal microbiome scientists at Juno Bio.
Easy-to-use BV and AV treatment program.
Promote and support a protective vaginal microbiome with tailored probiotic species.
